Archive for September 2026
MSN: Transforming sepsis care: How host-response technology enables rapid, actionable diagnosis
From the MSN article by Omar Alhassan Sepsis remains one of the most urgent clinical emergencies in modern healthcare. Each hour of delayed targeted treatment significantly increases patient mortality. For decades, intensive care and emergency clinicians have struggled with the critical challenge of distinguishing sepsis from non-infectious systemic inflammation. Conventional culture tests take days, and…
Read MoreSequential Application of Time-Stratified Demographic, Vital, Clinical–Laboratory, and Microbiology Variables for Accurate and Rapid Identification of Sepsis
From MDPI Diseases Abstract Background: Accurate early identification of sepsis remains a major clinical challenge due to its heterogeneous presentation and overlap of clinical signs with the non-infectious systemic inflammatory response syndrome (SIRS). Timely differentiation is crucial for improving patient outcomes, meeting sepsis bundle requirements and reducing inappropriate antimicrobial use. We hypothesized that clinical–laboratory data…
Read MoreNew Publication Supports the Role of SeptiCyte® RAPID To Improve Infection Diagnosis in Post Surgery and Trauma Patients
The study demonstrates strong performance distinguishing infection from sterile inflammation in post-op and trauma patients, when routine tests aren’t reliable. SEATTLE, WA, UNITED STATES, September 2, 2026 /EINPresswire.com/ — Immunexpress, a molecular diagnostics company focused on improving outcomes for patients with suspected sepsis, today announced the publication of a new study which highlights the potential of SeptiCyte® RAPID to address…
Read MoreValidation of SeptiCyte RAPID to Discriminate Sepsis From Noninfectious Systemic Inflammation in Critically Ill Children
From the Pediatric Critical Care Medicine article Conclusions: SeptiCyte RAPID demonstrated similar performance characteristics in children to that previously reported for adults. Additional real world effectiveness studies are warranted to determine real-time clinical utility, patient benefits, and health economic impact. Source: Pediatric Critical Care Medicine on PubMed
Read More